How Weight-Loss Drugs Are Changing the Fight Against Teen Obesity

With one in five American teens affected by obesity, the search for effective solutions has never been more critical. For years, the advice was limited to diet and exercise, often with disappointing results. The landscape shifted in 2022 when Wegovy received approval for adolescent use, offering new hope. This report delves into the experiences of 10 families whose teens have embarked on treatment with Wegovy or similar medications. Through a year of in-depth follow-up, we uncover the real-world impact of these drugs on young lives. Discover the challenges, breakthroughs, and future possibilities in the battle against teen obesity.